Xtant Medical Holdings Inc (XTNT) (Q2 2026) Earnings Call Highlights: Strategic Expansion Amid ...
Xtant Medical Holdings, Inc. Q2 2026 Earnings Call Summary
Xtant Medical Reports Second Quarter 2026 Financial Results
Xtant Medical Holdings, Inc. (XTNT) Q2 2026 Earnings Call Transcript
Xtant Medical Hldgs Q2 Adj. EPS $(0.03) Misses $(0.02) Estimate, Sales $23.031M Miss $24.875M Estimate
Xtant Medical Hldgs Lowers FY2026 Sales Guidance from $101.000M-$105.000M to $99.000M-$103.000M vs $102.058M Est
Xtant Medical to Announce Second Quarter 2026 Financial Results on August 11, 2026
Xtant Medical to Participate in the Canaccord Genuity 46th Annual Growth Conference
Xtant Medical Q1 Earnings Call Highlights
Xtant Medical Holdings, Inc. Q1 2026 Earnings Call Summary
Xtant Medical Holdings Inc (XTNT) Q1 2026 Earnings Call Highlights: Navigating Challenges and ...
Xtant Medical Holdings, Inc. (XTNT) Q1 2026 Earnings Call Transcript
BTIG Reiterates Buy on Xtant Medical Holdings, Maintains $1 Price Target
Xtant Medical Reports First Quarter 2026 Financial Results
Xtant Medical Hldgs Q1 2026 Earnings Call Transcript
Xtant Medical Raises FY2026 Sales Guidance from $95.000M-$99.000M to $101.000M-$105.000M vs $96.725M Est
Xtant Medical Hldgs Q1 EPS $(0.02), Inline, Sales $20.884M Beat $20.164M Estimate
Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026
Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped
Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.